Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07699458

Impact of Adding Integrated Neuromuscular Inhibition Technique to Cervical Stabilization Exercise in Chronic Mechanical Neck Pain

the goal of this clinical trial is to study the Impact of adding integrated neuromuscular inhibition technique to cervical stabilization exercise in chronic mechanical neck pain

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–44 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age from 18-44 year
  • Their body mass index will be ranging from (18-25) Kg/m2
  • All patient has active cervical trigger point of the upper fiber of the Trapezius detected by pincer palpation
  • Subjects must have characteristics of trigger points hardened, thickened taut bands in MPS patients.

Exclusion criteria

  • Individuals with a recent history of neck or back surgery.
  • Individuals with recent history of trauma or fracture.
  • Individuals with congenital and pathological disorders of the cervical spine.
  • Individuals with any psychiatric diseases

Treatment and study plan

Cervical stabilization exercise and Integrated Neuromuscular Inhibition

Device

cervical stablization exercise starting with cervical isometric exercises performed in the supine position. The head will be supported on a pillow with a towel roll placed under the cervical spine to ensure proper alignment. Additional cervical isometric exercises will be conducted in the seated position by applying manual resistance at the forehead to perform cervical flexion, extension, rotation, and side-bending movements. The Integrated Neuromuscular Inhibition will be applied to the upper trapezius muscle to deactivate myofascial trigger points and reduce muscle tension. The technique will consist of three sequential components: intermittent ischemic compression, strain counterstain, and muscle energy technique

Integrated neuromuscular inhibition technique

Device

Integrated Neuromuscular Inhibition will be applied to the upper trapezius muscle to deactivate myofascial trigger points and reduce muscle tension. The technique will consist of three sequential components: intermittent ischemic compression, strain counterstain, and muscle energy technique

conventional treatment group

Other

Participants in this group will receive conventional physical therapy only in the form of superficial heat using hot pack for 10 minutes, stretching exercise, isometric neck exercise and posture advice for 3 sessions/week over 4 weeks' periods.

Primary outcomes

  1. Pain threshold

    Time frame: One month

    Measured by using Pressure algometer

Secondary outcomes

  1. pain intensity

    Time frame: One month

    Measured by using Visual Analog Scale

  2. Range of Motion

    Time frame: One month

    Measured by using mobile application clinometer

  3. Neck function

    Time frame: One month

    Measured by using neck disability index

  4. Neck proprioception

    Time frame: One month

    Measured by using mobile application clinometer

Study contacts

Contact information is provided by the study sponsor or research team.

huda adel mohammed, assistant lecturer

CONTACT

[email protected]

+201283866669

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jul 13, 2026
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.